论文部分内容阅读
目的观察阿司匹林联合氯吡格雷治疗脑梗死的临床效果。方法选取90例脑梗死患者,随机分为观察组和对照A组、对照B组,每组30例。观察组采用阿司匹林联合氯吡格雷治疗,对照A组采用阿司匹林治疗,对照B组采用氯吡格雷治疗,3组疗程均为30d。比较3组总有效率及美国国立卫生研究院卒中量表(NIHSS)评分改善情况。结果观察组总有效率为96.67%,高于对照A组的70.00%和对照B组的63.33%,差异有统计学意义(P<0.05)。治疗30d后,3组NIHSS评分均低于治疗前,且观察组低于对照组A组和对照B组,差异有统计学意义(P<0.05)。结论阿司匹林联合氯吡格雷治疗脑梗死临床效果满意,可提高患者预后质量,值得临床推广应用。
Objective To observe the clinical effect of aspirin combined with clopidogrel in the treatment of cerebral infarction. Methods 90 patients with cerebral infarction were randomly divided into observation group and control group A, control group B, 30 cases in each group. The observation group was treated with aspirin combined with clopidogrel, the control group A was treated with aspirin, the control group B was treated with clopidogrel, and the three courses of treatment were 30 days. The total effective rate was compared between the three groups and the NIH Stroke Scale (NIHSS) score was improved. Results The total effective rate in observation group was 96.67%, which was higher than 70.00% in control group A and 63.33% in control group B, the difference was statistically significant (P <0.05). After 30 days of treatment, NIHSS scores of three groups were lower than before treatment, and the observation group was lower than the control group A and control group B, the difference was statistically significant (P <0.05). Conclusion Aspirin combined with clopidogrel is effective in treating cerebral infarction, which can improve the quality of prognosis of patients and is worthy of clinical application.